Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin
Florus C. de Jong(Erasmus MC Cancer Institute), Tahlita C.M. Zuiverloon(Erasmus MC), James C. Costello(University of Colorado Cancer Center), Robert F. Hoedemaeker(PathoFinder (Netherlands)), Deric K. E. van der Schoot(Amphia Ziekenhuis), Teemu D. Laajala(University of Turku), Tokameh Mahmoudi(Erasmus MC), Joost L. Boormans(Erasmus MC), Bart Nieuwkamer(Reinier de Graaf Hospital), Egbert R. Boevé(Hôpitaux Universitaires Henri-Mondor), Angelique C. J. van der Made(Erasmus MC), Emiel A. M. Janssen(Stavanger University Hospital), Kimberley R. Jordan(University of Colorado Anschutz Medical Campus), Dan Theodorescu(University of Arizona)
Cited by 89
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Advances in bladder cancer biology and therapy
|Nature reviews. Cancer|2020|783